SUPERNUS PHARMACEUTICALS, INC. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SUPERNUS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SUPERNUS PHARMACEUTICALS, INC. for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Option Exercise | M | 5.88 | 15,000 | 88,200 | 25,000 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Option Exercise | M | 7.90 | 23,481 | 185,500 | 20,000 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Option Exercise | M | 5.88 | 15,000 | 88,200 | 40,000 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Option Exercise | M | 7.90 | 26,519 | 209,500 | 43,481 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Buy | M | 5.88 | 15,000 | 88,200 | 30,716 | 15.7 K to 30.7 K (+95.44 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Sell | S | 48.89 | 23,481 | 1,147,965 | 15,716 | 39.2 K to 15.7 K (-59.91 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Buy | M | 7.90 | 23,481 | 185,500 | 39,197 | 15.7 K to 39.2 K (+149.41 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Buy | M | 5.88 | 15,000 | 88,200 | 15,716 | 716 to 15.7 K (+2,094.97 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Sell | S | 48.00 | 1,519 | 72,912 | 716 | 2.2 K to 716 (-67.96 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Sell | S | 46.36 | 25,000 | 1,158,903 | 2,235 | 27.2 K to 2.2 K (-91.79 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | PATRICK GREGORY S | VP, Chief Financial ... | Buy | M | 7.90 | 26,519 | 209,500 | 27,235 | 716 to 27.2 K (+3,703.77 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 12.92 | 95,000 | 1,227,400 | 0 | |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Sell | S | 46.59 | 95,000 | 4,425,575 | 1,855 | 96.9 K to 1.9 K (-98.08 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Buy | M | 12.92 | 95,000 | 1,227,400 | 96,855 | 1.9 K to 96.9 K (+5,121.29 %) |
| Sep 11 2017 | SUPN | SUPERNUS PHARMACEU ... | Bhatt Padmanabh P. | Sr VP of IP, CSO | Sell | S | 49.86 | 5,000 | 249,303 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |